Pulmonary fibrosis is a serious condition in which scar tissue develops in the lungs. This makes it increasingly difficult to breathe properly. The disease usually progresses slowly but irreversibly, making it hard to reverse the damage. Until now, treatments have existed that can slow down the process, but a complete cure is not yet possible.
Researchers have now looked at the role of two genes, ID1 and ID3, which are more active than normal in pulmonary fibrosis. By reducing the activity of these genes, it was possible to partially reverse scarring in animal models. This offers new hope for the development of more effective therapies.
This approach is different from previous strategies, which focused, for example, on the removal of so-called senescent cells. Senescent cells are old cells that no longer function properly and can exacerbate damage. The new method focuses on directly modifying gene expression to stimulate the repair process.
The research is still at an early stage, but shows that it is possible not only to slow the progression of pulmonary fibrosis, but also partly to reverse it. This is an important step in the search for treatments that can improve lung health and quality of life.
For everyone interested in healthy ageing, this is hopeful news, as it shows that genetic technologies can contribute to better care for chronic lung conditions.
Source: Reason
